Bacteraemic pneumococcal pneumonia in COPD patients: Better outcomes than expected

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 8, 2009, Pages 971-976

  Calbo, E ^a   Valdes E ^b   Ochoa De Echaguen A ^a   Fleites, A ^b   Molinos, L ^b   Xercavins, M ^a   Freixas, N ^a   Rodriguez Carballeira M ^a   Garau, J ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b Hospital Universitario   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTEREMIC STREPTOCOCCUS PNEUMONIA; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; LENGTH OF STAY; MALE; MALIGNANT NEOPLASTIC DISEASE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SHOCK; STREPTOCOCCUS PNEUMONIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEROTYPING; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 68849095411     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-009-0737-1     Document Type: Article

References (34)

1. LA Mandell 2004 Epidemiology and etiology of community-acquired pneumonia Infect Dis Clin North Am 18 761 776 10.1016/j.idc.2004.08.003 (Pubitemid 39536007)
2. RC Tilgham M Finland 1937 Clinical significance of bacteremia in pneumococcal pneumonia Arch Intern Med 59 601 612
3. R Austrian J Gold 1964 Pneumococcal bacteraemia with especial reference to bacteremic pneumococcal pneumonia Ann Intern Med 60 759 770
4. JA Brandenburg TJ Marrie CM Coley 2000 Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia J Gen Intern Med 15 638 646 10.1046/j.1525-1497.2000.04429.x (Pubitemid 30768403)
5. B Afessa WL Greaves WR Frederick 1995 Pneumococcal bacteremia in adults: a 14 year experience in an inner-city university hospital Clin Infect Dis 21 345 351
6. LA Mandell RG Wunderink A Anzueto 2007 Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults Clin Infect Dis 44( Suppl 27 72 10.1086/511159 (Pubitemid 46290553)
7. BM Farr AJ Sloman MJ Fisch 1991 Predicting death in patients hospitalized for community-acquired pneumonia Ann Intern Med 115 428 436
8. BM Farr MA Woodhead JT Macfarlane 2000 Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community Respir Med 94 422 427 10.1053/rmed.1999.0743 (Pubitemid 30352997)
9. F Gutierrez M Masia JC Rodriguez 2005 Epidemiology of community-acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain Clin Microbiol Infect 11 788 800 10.1111/j.1469-0691.2005.01226.x (Pubitemid 41341711)
10. M Falguera M Martin A Ruiz-Gonzalez 2005 Community-acquired pneumonia as the initial manifestation of serious underlying diseases Am J Med 118 378 383 10.1016/j.amjmed.2005.01.011 (Pubitemid 40460996)
11. MJ Fine MA Smith CA Carson 1996 Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis JAMA 275 134 141 10.1001/jama.275.2.134 (Pubitemid 26021681)
12. ME Charlson P Pompei KL Ales 1987 A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 373 383 10.1016/0021-9681(87) 90171-8
13. MJ Fine TE Auble DM Yealy 1997 A prediction rule to identify low-risk patients with community-acquired pneumonia N Engl J Med 336 243 250 10.1056/NEJM199701233360402 (Pubitemid 27044625)
14. Clinical and Laboratory Standards Institute/NCCLS (2007) Performance standards for antimicrobial susceptibility testing. 17th informational supplement. CLSI document M100-S17. CLSI, Wayne, PA
15. MI Restrepo EM Mortensen JA Pugh 2006 COPD is associated with increased mortality in patients with community-acquired pneumonia Eur Respir J 28 346 351 10.1183/09031936.06.00131905 (Pubitemid 44914234)
16. R Pifarre M Falguera C Vicente-de-Vera 2007 Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease Respir Med 101 2139 2144 10.1016/j.rmed.2007.05.011 (Pubitemid 47324242)
17. J Rello A Rodriguez A Torres 2006 Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Eur Respir J 27 1210 1216 10.1183/09031936.06.00139305 (Pubitemid 44914306)
18. VL Yu CC Chiou C Feldman 2003 An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome Clin Infect Dis 37 230 237 10.1086/377534 (Pubitemid 36930354)
19. R Pallares J Linares M Vadillo 1995 Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Engl J Med 333 474 480 10.1056/NEJM199508243330802
20. MR Kramer B Rudensky I Hadas-Halpenirin 1987 Pneumococcal bacteremia-no change in mortality in 30 years: analysis of 104 cases and review of the literature Isr J Med Sci 23 174 180
21. R Chokshi MI Restrepo N Weeratunge 2007 Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia Eur J Clin Microbiol Infect Dis 26 447 451 10.1007/s10096-007-0307-3 (Pubitemid 47025032)
22. MA Mufson RJ Stanek 1999 Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997 Am J Med 107 Suppl 34 43 10.1016/S0002-9343(99)00098-4
23. J Aspa O Rajas FR de Castro 2006 Impact of initial antibiotic choice on mortality from pneumococcal pneumonia Eur Respir J 27 1010 1019
24. DR Feikin A Schuchat M Kolczak 2000 Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997 Am J Public Health 90 223 229 10.2105/AJPH.90.2.223
25. M Lujan M Gallego D Fontanals 2004 Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality Crit Care Med 32 625 631 10.1097/01.CCM.0000114817.58194.BF (Pubitemid 38340054)
26. I Tager FE Speizer 1975 Role of infection in chronic bronchitis N Engl J Med 292 563 571
27. TF Murphy S Sethi 1992 Bacterial infection in chronic obstructive pulmonary disease Am Rev Respir Dis 146 1067 1083
28. F Dallaire N Oullet Y Bergeron 2001 Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia J Infect Dis 184 292 300 10.1086/322021 (Pubitemid 32662175)
29. JR Catterall 1999 Streptococcus pneumoniae Thorax 54 929 937
30. D Bogaert P van der Valk R Ramdin 2004 Host-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary disease Infect Immun 72 818 823 10.1128/IAI.72.2.818-823.2004 (Pubitemid 38166660)
31. M Confalonieri R Urbino A Potena 2005 Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study Am J Respir Crit Care Med 171 242 248 10.1164/rccm.200406-808OC
32. C Garcia-Vidal E Calbo V Pascual 2007 Effects of systemic steroids in patients with severe community-acquired pneumonia Eur Respir J 30 951 956 10.1183/09031936.00027607 (Pubitemid 351194800)
33. MJ Bonten AH Froon CA Gaillard 1997 The systemic inflammatory response in the development of ventilator-associated pneumonia Am J Respir Crit Care Med 156 1105 1113
34. P Kumashi E Girgawy JJ Tarrand 2005 Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002) Medicine (Baltimore) 84 303 312 10.1097/01.md.0000180045.26909.29 (Pubitemid 41368483)